- Home
- CHY vs INNV Comparison
CHY vs INNV Comparison
Compare CHY & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHY
- INNV
- Stock Information
- Founded
- CHY 2003
- INNV 2007
- Country
- CHY United States
- INNV United States
- Employees
- CHY N/A
- INNV N/A
- Industry
- CHY Investment Managers
- INNV Medical/Nursing Services
- Sector
- CHY Finance
- INNV Health Care
- Exchange
- CHY Nasdaq
- INNV Nasdaq
- Market Cap
- CHY 934.9M
- INNV 817.8M
- IPO Year
- CHY N/A
- INNV 2021
- Fundamental
- Price
- CHY $11.54
- INNV $3.70
- Analyst Decision
- CHY
- INNV Hold
- Analyst Count
- CHY 0
- INNV 3
- Target Price
- CHY N/A
- INNV $6.00
- AVG Volume (30 Days)
- CHY 128.3K
- INNV 74.3K
- Earning Date
- CHY 01-01-0001
- INNV 02-04-2025
- Dividend Yield
- CHY 10.11%
- INNV N/A
- EPS Growth
- CHY N/A
- INNV N/A
- EPS
- CHY N/A
- INNV N/A
- Revenue
- CHY N/A
- INNV $786,512,000.00
- Revenue This Year
- CHY N/A
- INNV $13.33
- Revenue Next Year
- CHY N/A
- INNV $10.23
- P/E Ratio
- CHY N/A
- INNV N/A
- Revenue Growth
- CHY N/A
- INNV 12.46
- 52 Week Low
- CHY $9.97
- INNV $3.50
- 52 Week High
- CHY $12.16
- INNV $6.69
- Technical
- Relative Strength Index (RSI)
- CHY 34.53
- INNV 38.76
- Support Level
- CHY $11.58
- INNV $3.52
- Resistance Level
- CHY $11.85
- INNV $3.83
- Average True Range (ATR)
- CHY 0.22
- INNV 0.25
- MACD
- CHY -0.03
- INNV 0.03
- Stochastic Oscillator
- CHY 10.68
- INNV 23.40
About CHY Calamos Convertible and High Income Fund
Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high yield securities.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.